University of Manchester, UK.
Cancer Treat Rev. 2010 Jun;36(4):286-97. doi: 10.1016/j.ctrv.2010.02.004. Epub 2010 Mar 12.
The acute leukaemias account for about 30% of all malignancy seen in childhood across the Western world. A peak incidence of precursor B cell ALL has emerged as socio-economic conditions have improved in countries worldwide. From twin studies and the use of neonatal blood spots it has been possible to back track the first initiating genetic events within critical haemopoietic cells to foetal development in utero for most precursor B cell ALL and some cases of AML. These events may occur as part of normal foetal development. Whether other factors (environmental or constitutional) are involved to increase the chance of these first genetic changes happening is unclear. For some leukaemias (e.g. infant MLL positive ALL) the first event appears adequate to create a malignant clone but for the majority of ALL and AML further 'genetic' changes are required, probably postnatal. Many environmental factors have been proposed as causative for leukaemia but only ionising irradiation and certain chemicals, e.g. benzene and cytotoxics (alkylators and topoisomerase II inhibitors) have been confirmed and then principally for acute myeloid leukaemia. It appears increasingly likely that delayed, dysregulated responses to 'common' infectious agents play a major part in the conversion of pre-leukaemic clones into overt precursor B cell ALL, the most common form of childhood leukaemia. Constitutional polymorphic alleleic variants in immune response genes (especially the HLA Class II proteins) and cytokines may play a role in determining the type of immune response. High penetrance germ-line mutations are involved in only about 5% of childhood leukaemias (more in AML than ALL). There is little evidence to support any role of viral transformation in causation, unlike in animals. Other environmental factors for which some evidence exists include non-ionising electromagnetic radiation and electric fields, although their mode of action in leukaemogenesis remains unclear. There is no single cause for childhood leukaemia and for most individuals a combination of factors appears to be necessary; all involving gene-environment interactions. To date few clear preventative measures have emerged, except the complete avoidance of first trimester X-rays in pregnancy; a healthy diet with adequate oral folic acid intake both preconception and early in pregnancy; and the early exposure of children to other children outside the home to facilitate stimulation and maturation of the natural immune system. Here then are clear echoes of the "hygiene hypothesis" regarding the initiation of allergies, autoimmune disease and type I diabetes mellitus in children and young people.
在整个西方世界,急性白血病约占儿童所有恶性肿瘤的 30%。随着世界各国社会经济条件的改善,前体 B 细胞 ALL 的发病率达到高峰。从双胞胎研究和新生儿血斑的应用中,可以追溯到大多数前体 B 细胞 ALL 和一些 AML 病例中关键造血细胞内最初遗传事件的发生。这些事件可能是胎儿发育过程中的正常一部分。是否存在其他因素(环境或体质)增加这些最初遗传变化发生的机会尚不清楚。对于一些白血病(例如婴儿 MLL 阳性 ALL),最初的事件似乎足以产生恶性克隆,但对于大多数 ALL 和 AML,则需要进一步的“遗传”变化,可能是在出生后。已经提出了许多环境因素作为白血病的致病因素,但只有电离辐射和某些化学物质,如苯和细胞毒素(烷化剂和拓扑异构酶 II 抑制剂)得到了证实,主要用于急性髓细胞性白血病。越来越多的证据表明,对“常见”感染因子的延迟、失调反应在白血病前克隆转化为明显的前体 B 细胞 ALL 中起着重要作用,前体 B 细胞 ALL 是儿童中最常见的白血病形式。免疫反应基因(尤其是 HLA Ⅱ类蛋白)和细胞因子中的免疫反应的结构多态性等位基因变异可能在决定免疫反应类型方面发挥作用。高外显率的种系突变仅涉及约 5%的儿童白血病(AML 多于 ALL)。几乎没有证据支持病毒转化在病因中的任何作用,与动物不同。还有一些证据表明,其他环境因素包括非电离电磁辐射和电场,但它们在白血病发生中的作用机制尚不清楚。儿童白血病没有单一的病因,对于大多数个体来说,似乎需要多种因素的组合;所有这些因素都涉及基因-环境相互作用。到目前为止,除了在怀孕期间完全避免妊娠早期的 X 射线外,很少有明确的预防措施出现;在怀孕前和怀孕早期,通过健康饮食摄入足够的口服叶酸;以及让儿童尽早接触家庭以外的其他儿童,以促进自然免疫系统的刺激和成熟。这与儿童和年轻人过敏、自身免疫性疾病和 I 型糖尿病的“卫生假说”有明显的相似之处。